Mouse Anti-Human CD25 Antibody (S-R494)

產(chǎn)品型號(hào)：S0B0921

更新時(shí)間：2025-07-11

廠商性質(zhì)：生產(chǎn)廠家

訪問(wèn)量：39

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

1h快速定量Total IgG

戰(zhàn)“疫”新動(dòng)向：KP.2蛋白原料上新

腫瘤靶點(diǎn)的“新寵”-Claudin18.2抗體現(xiàn)貨！

Anti-RFP/mcherry瓊脂糖珠：純化熒光標(biāo)簽蛋白

產(chǎn)品介紹

CD25, also known as the alpha chain of the interleukin-2 receptor （IL-2Rα）, is a protein marker predominantly found on the surface of activated T cells, B cells, and regulatory T cells （Tregs）. It plays a crucial role in the immune response by binding to interleukin-2, which is vital for T cell proliferation and immune cell signaling. CD25 is also used as a marker to identify and characterize Tregs, which are essential in maintaining immune system homeostasis and preventing autoimmune reactions. High expression of CD25 is often associated with immune activation, and its levels can be indicative of various immune-related conditions, including autoimmune diseases and cancer. In the context of cancer, CD25 can be a potential target for immunotherapy, as it is highly expressed on Tregs that can suppress anti-tumor immune responses. Targeting CD25 may help in depleting Tregs and enhancing the effectiveness of immune treatments.

上一個(gè)：S0B0923Mouse Anti-Human CD28 Antibody (S-R495-2)